TCT conference @ formnext 2018 Agenda
To find out more about the presentations at the TCT conference @ formnext, please see the programme below.
Johnson & Johnson is investing in 3D printing to disrupt and evolve healthcare solutions. The company is embracing an end-to-end approach across the enterprise and leverages expertise from an extensive network of partners. They are changing the design, manufacture and delivery ecosystems for medical devices, consumer products, and pharmaceutical businesses. This presentation will evaluate how Johnson & Johnson is integrating additive manufacturing to connect with patients and providers at every touchpoint of care.
Presentation Level: Beginner
Additive manufacturing offers new possibilities in the production of next-generation drugs and medical devices. The FDA’s recent approval of Aprecia Pharmaceuticals’ 3D printed epilepsy drug Spritam is likely to be just the first of many new products to come to market as AM matures and its prices decrease.
Although 3D technologies present great opportunities, they come with challenges, especially when it comes to intellectual property laws. MedTech manufacturers, for instance, have to know whether the existing patents cover the distribution of a 3D printing files. They also need advice on whether the current, centralised manufacturing models will become less attractive than the ones offered my AM technologies.
This presentation will examine how MedTech manufacturers can adapt quickly to the changes driven by 3D printing in the healthcare industry.
Medical 3D printing is a relatively new and a very promising technique. However, still only a few hospitals use 3D printing to improve patient care and medical outcomes. Dr. Lars Brouwers, Surgical Resident in Training and PhD Candidate, and Dr. Mike Bemelman, Trauma and War Surgeon from the Elisabeth-Tweesteden hospital in Tilburg, the Netherlands are the founding fathers of a non-profit low-budget, in-house medical 3D lab which provides 3D prints for surgeons, resident, students and patients. They perform a lot of medical research to investigate the added value of 3D printing in complex fractures and received the technical Innovation award from the European Society for Surgical research and Orthopaedic Trauma Association award from the American and Canadian Trauma Society for their outstanding work. In this talk, Lars Brouwers will discuss the added value of 3D printed models in extension of X-ray and CT for preoperative work, as well as the cost-effectiveness of 3D printing.
All amputees have different stories to tell, share various interests and have distinct ways of expressing themselves. Glaze Prosthetics addresses their users’ diverse needs by creating innovative upper limb systems. The replaceable arms can interchange in less than three seconds and come in stylish shapes and colours. This presentation will evaluate how Glaze Prosthetics uses SLS technology to develop their customisable devices and how they revolutionise the prosthetics industry.
Presentation Level: Intermediate
In the future, we will see the personalisation of medication for the patient’s individual needs. Additive manufacturing has the potential to revolutionise the pharmaceutical industry. 3D printing will enable the production of dosage forms with custom-fit ingredients and optimised release profiles. Building on research developed at the University of Nottingham, this presentation will examine the industrialisation of pharmaceutical printing. Ricky Wildman, Professor of Additive Manufacturing at the University of Nottingham, will share the findings and will look at what’s to come.
Fabrication of porous scaffolds with complex internal architecture for bone substitution application has been the focus of the researches at the University of Padova for many years. This presentation will review micro direct metal deposition (µDMD) and selective laser melting (SLM) processes, capable of printing microfeatures. Micropores, for instance, are an essential aspect which can mimic the internal structure of real bone. Saeed Khademzadeh, Researcher at the University of Padova, will examine the production and characterisation of the porous scaffolds made from biocompatible materials such as titanium and shape memory alloy.
Presentation Level: Intermediate
Brightlands Materials Center focuses on building additive manufacturing knowledge of photocurable and functional materials and on vat photopolymerisation. The institute also develops thermally and electrically conductive materials as well as coloured, permeable, hydrophilic and hydrophobic filaments. Scientists at Brightlands believe that their recent research findings will enable an extension of possibilities in vat photopolymerisation applications.
This presentation will examine how Brightlands Materials Center created a photo-curable, 3D printable and permeable, material for substrate cell growth applications. The session will discuss its possible use in membrane and filtration technologies, catalysis, damping and light-weight material advancements.
Presentation Level: Advanced
Additive manufacturing enables the development of alloys with unique microstructures. The processing of Ti-6Al-4V, IN718, SS316 and AlSiMg materials, however, requires an understanding of the intricate relationship between feedstock properties, processing conditions, microstructure complexity and mechanical integrity. The first part of the presentation will thus look at data-driven modelling approach, computer vision and machine learning, which aids the extraction of data trends.
The second part of the presentation will look at recycled powder and its ability to reduce the costs during serial production. Bij-Na Kim will introduce a predictive model that captures the influence of powder evolution on the part properties. The predictive capability of the model can be utilised for alloy design tailored to the AM processes and can address the feedstock requirements during serial production within the design procedure.
Presentation Level: Advanced
When it comes to plastic component manufacturing, there a limited choice of FLM materials. In comparison, there is a broad range of plastics available for injection moulding. These can be ten times less expensive than filaments and, for this reason, plastic granule processing for additive manufacturing of high-volume components is in demand.
This presentation will look at the development and implementation of a granulate-based extruder, based on a six-axis robot handling system, in an automated environment. It will examine how the Technische Universität Ilmenau team designed temperature and material (PC/ABS and SAN) dependent extruder output and a theoretical model of strand geometry which fulfils the function of process parameters.
Leander Schmidt will explain the validation stages of the model and will compare the targeted and actual strand geometry tests. He will also examine the development of process windows and the information they provide about the technical applicability of the granule-based strand deposition process.